Výsledky vyhledávání - "Rho Chi Huang"

Supplementary figures and legends from Suppression of Extracellular Vesicle VEGF-C–mediated Lymphangiogenesis and Pancreatic Cancer Early Dissemination By a Selective HDAC1/2 Inhibitor

Autor: Shaw-Jenq Tsai, Jing-Ping Liou, Yo-Hua Li, Rho-Chi Huang, Chien-Feng Li, Chu-An Wang

Supplementary data includes IC50 of SAHA and B390 (S1),bioinformatic analysis (S2 and S3), and tumor size (S4)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d43b71b29209385cbccf6f8ec4c219
https://doi.org/10.1158/1535-7163.22522542.v1

Zobrazit plný text záznamu

Data from Suppression of Extracellular Vesicle VEGF-C–mediated Lymphangiogenesis and Pancreatic Cancer Early Dissemination By a Selective HDAC1/2 Inhibitor

Autor: Shaw-Jenq Tsai, Jing-Ping Liou, Yo-Hua Li, Rho-Chi Huang, Chien-Feng Li, Chu-An Wang

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer characterized by early dissemination and poor drug response. Therefore, it is an unmet medical need to develop new strategies for treatment. As aberrant activation of ERK due to KR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1030c6e663bf2a789641d9044ad53828
https://doi.org/10.1158/1535-7163.c.6543423.v1

Zobrazit plný text záznamu

Suppression of Extracellular Vesicle VEGF-C–mediated Lymphangiogenesis and Pancreatic Cancer Early Dissemination By a Selective HDAC1/2 Inhibitor

Autor: Jing Ping Liou, Shaw Jenq Tsai, Rho Chi Huang, Yo Hua Li, Chu An Wang, Chien Feng Li

Publikováno v: Molecular Cancer Therapeutics. 20:1550-1560

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd7cdf70e7d43f15bcad0303d43adfc
https://doi.org/10.1158/1535-7163.mct-20-0963

Zobrazit plný text záznamu

A novel HDAC inhibitor suppresses extracellular vesicle VEGF-C-mediated lymphangiogenesis and pancreatic cancer early dissemination

Autor: Chu-An Wang, Chien-Feng Li, Rho-Chi Huang, Yo-Hua Li, Jing-Ping Liou, Shaw-Jenq Tsai

Background Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer characterized by early dissemination and poor drug response. Loss-of-function of dual specificity phosphatase 2 (DUSP2), a critical regulator of MAPKs signaling, is high

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ec6e83d435ca546f71c874dc7346ea14
https://doi.org/10.21203/rs.3.rs-70831/v1

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání